Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Improving outcomes in hypertensive patients: Focus on adherence and persistence with antihypertensive therapy
The Journal of Clinical Hypertension, 06/25/09
Elliott WJ et al. – A review on outcomes in hypertensive pts reports improved outcomes with a focus on adherence and persistence with antihypertensive therapy.
Methods- Review on outcomes in hypertension
- Blood pressure (BP) control rates among treated pts in actual clinical practice are less than optimal despite effective BP control reducing risk of cardiovascular events in hypertension
- Costs of drugs and medical care are key but difficult to estimate both in clinical trials and general clinical practice
- Drug-taking behavior—adherence and persistence with antihypertensive regimens—influences BP control rates
- Rates vary greatly among antihypertensive classes based on many factors affecting pt adherence and persistence, including drug efficacy and tolerability
- Medications with fewer adverse effects associated with increased adherence and lower discontinuation rates
- Widespread use of these drugs (and generic or low-cost formulations) may lead to better long-term BP control and fewer cardiovascular events
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Obesity-Related Cardiorenal Syndrome
The Journal of Clinical Hypertension, 10/20/09
Pravastatin and cardiovascular risk in moderate chronic kidney disease
Atherosclerosis, 10/07/09
Article Search
Sponsor


See Latest Articles


